Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures ? Controlling High Dosage Buprenorphine abuse.
Pauly et al., Drug and Alcohol Dependence, 2011
2007, enquête OPPIDUM : consommations de méthadone et de buprénorphine haut dosage
Nordmann et al., Le Courrier des Addictions, 2009
2007, enquête OPPIDUM : consommations de méthadone et de buprénorphine haut dosage Lire la suite »
Le programme de surveillance OPPIDUM du Réseau des CEIPs : 20 ans d’expérience déjà !
Frauger et al., La Lettre du Pharmacologue, 2009
Second Meeting of the French CEIP, part I : How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs ?
Micallef et al., Thérapie, 2009
Estimation of Clonazepam abuse liability: a new method using a reimbursed drug database
Frauger et al., International Clinical Psychopharmacology, 2009
Consommation de cannabis en France : bilan de l’enquête nationale OPPIDUM
Micallef et al., La Lettre du Pharmacologue, 2009
Consommation de cannabis en France : bilan de l’enquête nationale OPPIDUM Lire la suite »
Medicines submitted to narcotics regulations in France, 1992-2007
Baumevieille et al., Fundamental & Clinical Pharmacology, 2009
Medicines submitted to narcotics regulations in France, 1992-2007 Lire la suite »
Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine
Pradel et al., Pharmacoepidemiology and Drug Safety, 2009